About The Digest
Using data derived from Beacon as of 7th of September, the slides cover the following:
- An overview of the current oligonucleotide space
- A review of the preclinical and clinical landscape of oligonucleotide therapeutics
- All new and updated drug and trial records published through September
Related content
Beacon RNA: AACR Post-Conference Report 2024
The 2023 RNA Landscape Review
RNA SITC Post-Conference Report 2023
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Speak with our Team
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
